Viyash Scientific Limited (BOM:512529)
201.30
+7.20 (3.71%)
At close: Jan 22, 2026
Viyash Scientific Employees
Viyash Scientific had 1,244 employees as of March 31, 2025. The number of employees increased by 49 or 4.10% compared to the previous year.
Employees
1,244
Change (1Y)
49
Growth (1Y)
4.10%
Revenue / Employee
13.33M INR
Profits / Employee
336.08K INR
Market Cap
87.71B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 1,244 | 49 | 4.10% |
| Mar 31, 2024 | 1,195 | -106 | -8.15% |
| Mar 31, 2023 | 1,301 | -470 | -26.54% |
| Mar 31, 2022 | 1,771 | 1 | 0.06% |
| Mar 31, 2021 | 1,770 | 70 | 4.12% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| FDC Limited | 6,857 |
| Jubilant Pharmova | 5,547 |
| CORONA Remedies | 4,508 |
| Granules India | 4,066 |
| Caplin Point Laboratories | 3,966 |
| Unichem Laboratories | 3,142 |
| Gufic Biosciences | 1,484 |
| Procter & Gamble Health | 1,326 |
Viyash Scientific News
- 2 months ago - Sequent Scientific Ltd (BOM:512529) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 2 months ago - Q2 2026 SeQuent Scientific Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - SeQuent Scientific shares jump over 10% as NCLT approves merger with Viyash Lifesciences - Business Upturn
- 8 months ago - Sequent Scientific Q4 Results: Revenue up 11% YoY to Rs 401 crore - Business Upturn
- 1 year ago - Sequent Scientific Ltd (BOM:512529) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - GuruFocus
- 1 year ago - Sequent Scientific Q3 FY25 results: Revenue up 18.7% YoY to Rs 390.8 crore, Net profit declines 58.5% YoY - Business Upturn
- 1 year ago - India's Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Benzinga
- 1 year ago - SeQuent Scientific consolidates ownership of subsidiaries in Sweden and Italy - Business Upturn